(Menopause[TA])
4,880 results
  • Inflammatory and immune biomarkers over midlife and future cognition in women: the SWAN HDL Ancillary Study. [Journal Article]
    Menopause. 2026 Aug 04. [Online ahead of print]Qi M, Derby CA, … El Khoudary SRM
  • CONCLUSIONS: Higher baseline GlycA, rather than its changes since baseline, was associated with lower future working memory, whereas higher baseline complement factor 4 and increases in C3 and C4 since baseline appeared cognitively protective. Targeting inflammation amelioration and immunity improvement over the menopause transition may provide an open avenue to preserve future cognitive health.
  • Menopause education in undergraduate medical curricula: a narrative review of teaching models, content gaps, and learner preparedness. [Journal Article]
    Menopause. 2026 Jul 28. [Online ahead of print]Bhatia R, Baker S, … Chadha KM
  • CONCLUSIONS: The literature search identified 1,305 records, of which 12 studies met inclusion criteria. Menopause education was inconsistently incorporated into undergraduate medical curricula and often embedded within broader primary care teaching rather than delivered as structured content. Although students generally demonstrated accurate recognition of menopausal symptoms, many showed gaps in management and counseling skills. Menopause education in undergraduate medical curricula is inconsistently delivered and lacks standardization. Development of a structured, competency-based menopause curriculum for undergraduate medical education may improve learner preparedness to better care for menopause patients.
  • Weight loss interventions and sexual function in midlife women: the emerging role of glucagon-like peptide-1 receptor agonists. [Journal Article]
    Menopause. 2026 Jul 28. [Online ahead of print]Castaneda R, Sepulveda D, … Faubion SSM
  • CONCLUSIONS: Obesity impairs female sexual function through hormonal, vascular, and psychosocial mechanisms. Accordingly, lifestyle interventions and bariatric surgery have demonstrated meaningful improvements in sexual function. In contrast, GLP-1 receptor agonists, despite conferring substantial weight loss and favorable metabolic effects, may paradoxically suppress sexual desire and arousal through central neuroendocrine mechanisms, including the modulation of dopaminergic reward and serotonergic signaling. While emerging case reports and preclinical data support this concern, systematic clinical evidence remains limited, highlighting the need for prospective studies with longitudinal sexual function endpoints. In this context, clinicians should proactively assess sexual function before and during GLP-1 therapy using validated instruments and integrate sexual health into comprehensive obesity care for midlife women.
  • The integration of migraine and sleep disturbance in perimenopause: a narrative review. [Journal Article]
    Menopause. 2026 Jul 28. [Online ahead of print]Heale R, Tait CM
  • CONCLUSIONS: An integrated approach to assessment and monitoring of migraine and sleep disorders during perimenopause, and treatment considerations impacting both conditions can reduce the burden of migraine and improve sleep. Coordination of treatment across both has the potential to improve quality of life of women in perimenopause. Further research is needed to better understand coordinated approaches to this complex interplay.
  • Psychological symptoms during perimenopause: a global perspective. [Journal Article]
    Menopause. 2026 Jul 28. [Online ahead of print]Cunningham AC, Hedges MS, … Shufelt CLM
  • CONCLUSIONS: Significantly greater psychological symptom burden was identified in the perimenopause group compared with the premenopause group, with the greatest difference noted for the individual symptom of exhaustion. Differences in symptom burden were also identified by country.
  • Dietary supplements for menopausal symptoms and health: a bibliometric analysis of US research (2000-2024). [Journal Article]
    Menopause. 2026 Jul 28. [Online ahead of print]Canino MC, Cohen B, … Gahche JJM
  • CONCLUSIONS: Dietary supplement research during the menopause transition has remained limited over the last two decades, with perimenopause notably underrepresented. The large number of distinct ingredients, coupled with limited collaborations among researchers, suggests dispersed research efforts and few replication studies. The imbalance between the number of ingredients studied and supporting studies may hinder the development of evidence-based guidance, but also presents an opportunity to harmonize research efforts and produce stronger science.